Related Experiment Video
Updated: Apr 3, 2026
Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
The ABCC4 membrane transporter modulates platelet aggregation
Satish B Cheepala1, Aaron Pitre1, Yu Fukuda1
1Department of Pharmaceutical Sciences.
Insights
The ATP-binding cassette (ABC) transporter ABCC4 is vital for platelet aggregation and thrombus formation. Its deficiency impairs collagen-induced platelet activation and enhances bleeding time, especially when combined with phosphodiesterase inhibition.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Platelet activation is critical for hemostasis and thrombosis, making it a target for cardiovascular disease treatment.
- The ATP-binding cassette (ABC) transporter ABCC4 was previously hypothesized to function within platelet-dense granules.
Purpose of the Study:
- To investigate the precise localization and function of ABCC4 in platelets.
- To elucidate the role of ABCC4 in platelet aggregation, thrombus formation, and its interaction with phosphodiesterases.
Main Methods:
- Plasma membrane biotinylation and super-resolution microscopy were used to determine ABCC4 localization in mouse and human platelets.
- Platelet aggregation assays, collagen substratum attachment studies, and ferric-chloride induced vascular injury models were employed.
- The effects of ABCC4 deficiency and phosphodiesterase inhibition (EHNA) on platelet function and bleeding were assessed.
Main Results:
- ABCC4 is primarily located on the plasma membrane of platelets, not dense granules.
- Abcc4 knockout (KO) platelets showed impaired collagen-induced aggregation, reduced attachment to collagen, and altered GPVI localization.
- Abcc4 KO mice exhibited defective thrombus formation and significantly prolonged bleeding times when treated with EHNA, indicating a synergistic effect.
Conclusions:
- ABCC4 plays a critical role in platelet aggregation and thrombus formation by regulating intracellular cyclic AMP (cAMP) levels and collagen receptor function.
- A significant functional interplay exists between ABCC4 and phosphodiesterases in controlling platelet activity.
- Targeting ABCC4 in conjunction with phosphodiesterase inhibitors presents a promising strategy for developing novel antithrombotic therapies.
Abstract:
Controlling the activation of platelets is a key strategy to mitigate cardiovascular disease. Previous studies have suggested that the ATP-binding cassette (ABC) transporter, ABCC4, functions in platelet-dense granules. Using plasma membrane biotinylation and super-resolution microscopy, we demonstrate that ABCC4 is primarily expressed on the plasma membrane of both mouse and human platelets. Platelets lacking ABCC4 have unchanged dense-granule function, number, and volume, but harbor a selective impairment in collagen-induced aggregation. Accordingly, Abcc4 knockout (KO) platelet attachment to a collagen substratum was also faulty and associated with elevated intracellular cyclic AMP (cAMP) and reduced plasma membrane localization of the major collagen receptor, GPVI. In the ferric-chloride vasculature injury model, Abcc4 KO mice exhibited markedly impaired thrombus formation. The attenuation of platelet aggregation by the phosphodiesterase inhibitor EHNA (a non-ABCC4 substrate), when combined with Abcc4 deficiency, illustrated a crucial functional interaction between phosphodiesterases and ABCC4. This was extended in vivo where EHNA dramatically prolonged the bleeding time, but only in Abcc4 KO mice. Further, we demonstrated in human platelets that ABCC4 inhibition, when coupled with phosphodiesterase inhibition, strongly impaired platelet aggregation. These findings have important clinical implications because they directly highlight an important relationship between ABCC4 transporter function and phosphodiesterases in accounting for the cAMP-directed activity of antithrombotic agents.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:17Intracellular Signaling Affects Focal Adhesions
Some...
01:19Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
01:27ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...